Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric Oxide

Antibiotic resistance poses a serious threat to global health. To reinforce the anti-infective arsenal, many novel therapeutic strategies to fight bacterial infections are being explored. Among them, anti-virulence therapies, which target pathways important for virulence, have attracted much attenti...

Full description

Bibliographic Details
Main Authors: Wen Kang Chou, Mathini Vaikunthan, Hendrik V. Schröder, A. James Link, Hahn Kim, Mark P. Brynildsen
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fbioe.2020.01001/full
_version_ 1818503239354548224
author Wen Kang Chou
Mathini Vaikunthan
Hendrik V. Schröder
A. James Link
A. James Link
A. James Link
Hahn Kim
Hahn Kim
Mark P. Brynildsen
author_facet Wen Kang Chou
Mathini Vaikunthan
Hendrik V. Schröder
A. James Link
A. James Link
A. James Link
Hahn Kim
Hahn Kim
Mark P. Brynildsen
author_sort Wen Kang Chou
collection DOAJ
description Antibiotic resistance poses a serious threat to global health. To reinforce the anti-infective arsenal, many novel therapeutic strategies to fight bacterial infections are being explored. Among them, anti-virulence therapies, which target pathways important for virulence, have attracted much attention. Nitric oxide (NO) defense systems have been identified as critical for the pathogenesis of various bacteria, making them an appealing therapeutic target. In this study, we performed chemical screens to identify inhibitors of NO detoxification in Escherichia coli. We found that 2-mercaptobenzothiazole (2-MBT) can potently inhibit cellular detoxification of NO, achieving a level of inhibition that resembled the effect of genetically removing Hmp, the dominant detoxification enzyme under oxygenated conditions. Further analysis revealed that in the presence of NO, 2-MBT impaired the catalysis of Hmp and synthesis of Hmp and other proteins, whereas in its absence there were minimal perturbations to growth and protein synthesis. In addition, by studying the structure-activity relationship of 2-MBT, we found that both sulfur atoms in 2-MBT were vital for its inhibition of NO detoxification. Interestingly, when 2-mercaptothiazole (2-MT), which lacked the benzene ring, was used, differing biological activities were observed, although they too were NO dependent. Specifically, 2-MT could still prohibit NO detoxification, though it did not interfere with Hmp catalysis; rather, it was a stronger inhibitor of protein synthesis and it reduced the transcript levels of hmp, which was not observed with 2-MBT. Overall, these results provide a strong foundation for further exploration of 2-MBT and 2-MT for therapeutic applications.
first_indexed 2024-12-10T21:21:24Z
format Article
id doaj.art-836565320a8d44f6b39a21eff98a15da
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-12-10T21:21:24Z
publishDate 2020-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-836565320a8d44f6b39a21eff98a15da2022-12-22T01:33:07ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852020-08-01810.3389/fbioe.2020.01001530958Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric OxideWen Kang Chou0Mathini Vaikunthan1Hendrik V. Schröder2A. James Link3A. James Link4A. James Link5Hahn Kim6Hahn Kim7Mark P. Brynildsen8Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ, United StatesDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, United StatesDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, United StatesDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, United StatesFrick Chemistry Laboratory, Department of Chemistry, Princeton University, Princeton, NJ, United StatesDepartment of Molecular Biology, Princeton University, Princeton, NJ, United StatesFrick Chemistry Laboratory, Department of Chemistry, Princeton University, Princeton, NJ, United StatesSmall Molecule Screening Center, Princeton University, Princeton, NJ, United StatesDepartment of Chemical and Biological Engineering, Princeton University, Princeton, NJ, United StatesAntibiotic resistance poses a serious threat to global health. To reinforce the anti-infective arsenal, many novel therapeutic strategies to fight bacterial infections are being explored. Among them, anti-virulence therapies, which target pathways important for virulence, have attracted much attention. Nitric oxide (NO) defense systems have been identified as critical for the pathogenesis of various bacteria, making them an appealing therapeutic target. In this study, we performed chemical screens to identify inhibitors of NO detoxification in Escherichia coli. We found that 2-mercaptobenzothiazole (2-MBT) can potently inhibit cellular detoxification of NO, achieving a level of inhibition that resembled the effect of genetically removing Hmp, the dominant detoxification enzyme under oxygenated conditions. Further analysis revealed that in the presence of NO, 2-MBT impaired the catalysis of Hmp and synthesis of Hmp and other proteins, whereas in its absence there were minimal perturbations to growth and protein synthesis. In addition, by studying the structure-activity relationship of 2-MBT, we found that both sulfur atoms in 2-MBT were vital for its inhibition of NO detoxification. Interestingly, when 2-mercaptothiazole (2-MT), which lacked the benzene ring, was used, differing biological activities were observed, although they too were NO dependent. Specifically, 2-MT could still prohibit NO detoxification, though it did not interfere with Hmp catalysis; rather, it was a stronger inhibitor of protein synthesis and it reduced the transcript levels of hmp, which was not observed with 2-MBT. Overall, these results provide a strong foundation for further exploration of 2-MBT and 2-MT for therapeutic applications.https://www.frontiersin.org/article/10.3389/fbioe.2020.01001/fullNOHmpthiazolehigh-throughput synergy screeningHTSS
spellingShingle Wen Kang Chou
Mathini Vaikunthan
Hendrik V. Schröder
A. James Link
A. James Link
A. James Link
Hahn Kim
Hahn Kim
Mark P. Brynildsen
Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric Oxide
Frontiers in Bioengineering and Biotechnology
NO
Hmp
thiazole
high-throughput synergy screening
HTSS
title Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric Oxide
title_full Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric Oxide
title_fullStr Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric Oxide
title_full_unstemmed Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric Oxide
title_short Synergy Screening Identifies a Compound That Selectively Enhances the Antibacterial Activity of Nitric Oxide
title_sort synergy screening identifies a compound that selectively enhances the antibacterial activity of nitric oxide
topic NO
Hmp
thiazole
high-throughput synergy screening
HTSS
url https://www.frontiersin.org/article/10.3389/fbioe.2020.01001/full
work_keys_str_mv AT wenkangchou synergyscreeningidentifiesacompoundthatselectivelyenhancestheantibacterialactivityofnitricoxide
AT mathinivaikunthan synergyscreeningidentifiesacompoundthatselectivelyenhancestheantibacterialactivityofnitricoxide
AT hendrikvschroder synergyscreeningidentifiesacompoundthatselectivelyenhancestheantibacterialactivityofnitricoxide
AT ajameslink synergyscreeningidentifiesacompoundthatselectivelyenhancestheantibacterialactivityofnitricoxide
AT ajameslink synergyscreeningidentifiesacompoundthatselectivelyenhancestheantibacterialactivityofnitricoxide
AT ajameslink synergyscreeningidentifiesacompoundthatselectivelyenhancestheantibacterialactivityofnitricoxide
AT hahnkim synergyscreeningidentifiesacompoundthatselectivelyenhancestheantibacterialactivityofnitricoxide
AT hahnkim synergyscreeningidentifiesacompoundthatselectivelyenhancestheantibacterialactivityofnitricoxide
AT markpbrynildsen synergyscreeningidentifiesacompoundthatselectivelyenhancestheantibacterialactivityofnitricoxide